These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6687375)

  • 1. In vitro degradation of atracurium in human plasma.
    Merrett RA; Thompson CW; Webb FW
    Br J Anaesth; 1983 Jan; 55(1):61-6. PubMed ID: 6687375
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro degradation of atracurium in human plasma.
    Stiller RL; Cook DR; Chakravorti S
    Br J Anaesth; 1985 Nov; 57(11):1085-8. PubMed ID: 3840382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of atracurium in plasma by high-performance liquid chromatography.
    Stiller RL; Brandom BW; Cook DR
    Anesth Analg; 1985 Jan; 64(1):58-62. PubMed ID: 3838124
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases.
    Foldes FF; Deery A
    Br J Anaesth; 1983; 55 Suppl 1():31S-34S. PubMed ID: 6134540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of atracurium besylate in healthy patients (after a single i.v. bolus dose).
    Ward S; Neill EA; Weatherley BC; Corall IM
    Br J Anaesth; 1983 Feb; 55(2):113-8. PubMed ID: 6687550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure).
    Ward S; Neill EA
    Br J Anaesth; 1983 Dec; 55(12):1169-72. PubMed ID: 6689126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of atracurium, laudanosine and related compounds in plasma by high-performance liquid chromatography.
    Simmonds RJ
    J Chromatogr; 1985 Oct; 343(2):431-6. PubMed ID: 3840807
    [No Abstract]   [Full Text] [Related]  

  • 8. A model for atracurium?
    Hull CJ
    Br J Anaesth; 1983 Feb; 55(2):95-6. PubMed ID: 6687551
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined pharmacokinetic and pharmacodynamic study of a single bolus dose of atracurium.
    Ward S; Wright D
    Br J Anaesth; 1983; 55 Suppl 1():35S-38S. PubMed ID: 6688015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the organ-independent elimination of cisatracurium.
    Kisor DF; Schmith VD; Wargin WA; Lien CA; Ornstein E; Cook DR
    Anesth Analg; 1996 Nov; 83(5):1065-71. PubMed ID: 8895287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudocholinesterase activity and atracurium v. suxamethonium block.
    Baraka A; Wakid N; Noueihed R; Karam H; Bolotova N
    Br J Anaesth; 1986; 58 Suppl 1():91S-95S. PubMed ID: 3011044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered i.v.
    Weatherley BC; Williams SG; Neill EA
    Br J Anaesth; 1983; 55 Suppl 1():39S-45S. PubMed ID: 6688016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic studies in the cat with atracurium: a neuromuscular blocking agent designed for non-enzymic inactivation at physiological pH.
    Neill EA; Chapple DJ
    Xenobiotica; 1982 Mar; 12(3):203-10. PubMed ID: 7113256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atracurium in obstetric anaesthesia. A preliminary report.
    Frank M; Flynn PJ; Hughes R
    Br J Anaesth; 1983; 55 Suppl 1():113S-114S. PubMed ID: 6688002
    [No Abstract]   [Full Text] [Related]  

  • 15. Unwanted isolated limb.
    Alegesan K
    Anaesthesia; 1983 Dec; 38(12):1230-1. PubMed ID: 6689249
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of atracurium in human and rat plasma.
    Nigrovic V; Pandya JB; Auen M; Wajskol A
    Anesth Analg; 1985 Nov; 64(11):1047-52. PubMed ID: 2932037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH and atracurium.
    Bolton DT
    Br J Anaesth; 1985 May; 57(5):545. PubMed ID: 3838900
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium.
    Varin F; Ducharme J; Théorêt Y; Besner JG; Bevan DR; Donati F
    Clin Pharmacol Ther; 1990 Jul; 48(1):18-25. PubMed ID: 2369806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atracurium: an overview.
    Hughes R
    Br J Anaesth; 1986; 58 Suppl 1():2S-5S. PubMed ID: 2423104
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic modelling of a parent drug and its metabolite. Atracurium and laudanosine.
    Nigrovic V; Banoub M
    Clin Pharmacokinet; 1992 May; 22(5):396-408. PubMed ID: 1505145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.